Product Details

Veroket is a sterile injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Ketorolac Tromethamine equivalent to 30mg Ketorolac per mL for use through the intramuscular (I.M.) or intravenous (I.V.) route. As a result, it offers potent, non-opioid analgesia for the short-term management of moderate to severe acute pain.

The injection contains:

• Ketorolac Tromethamine BP (equivalent to Ketorolac 30mg per mL) – A potent non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes. Consequently, it blocks prostaglandin synthesis and delivers strong analgesic effects comparable to opioid therapy, without opioid-related respiratory depression.
• Sterile Water for Injections IP (5ml, supplied separately) – The diluent supplied alongside the vial for use during administration.

Physicians use Veroket for the short-term management of moderate to severe acute pain, particularly in the post-operative setting, where it serves as an effective non-opioid alternative or adjunct. In addition, its dual-route (I.M./I.V.) formulation allows flexible administration based on clinical need. Because of this profile, Veroket suits hospitals and surgical units where potent, rapid-acting analgesia is required without opioid-related side effects.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the dual-route (I.M./I.V.) formulation offers flexible clinical use
• Furthermore, each vial delivers precise, validated dosage accuracy at 30mg/mL
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, the accompanying Sterile Water for Injections ampoule supports ready administration
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, surgical units, and pharmacies